OBJECTIVE: Vaginitis may be diagnosed as bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis, or coinfection. A new molecular test assays the vaginal microbiome and organisms that cause three common infections. The objective of the trial was to evaluate the clinical accuracy of the investigational test for vaginal swabs collected by patients (self) or clinicians. The primary and secondary outcomes were to compare the investigational test with reference methods for the three most common causes of vaginitis and compare cliniciancollected with self-collected swabs.
METHODS:
We conducted a cross-sectional study in which women with symptoms of vaginitis were recruited at ten clinical centers and consented to the investigation between May and September 2015. The woman collected a vaginal swab, sheathed, and then handed it to the clinician. These swabs were to evaluate how selfcollected swabs compared with clinician-collected swabs. The clinician collected an investigational test swab and reference test swabs. From 1,740 symptomatic patients, clinician-collected and self-collected vaginal swabs were evaluated by the molecular test and six tests. The reference methods for bacterial vaginosis were Nugent's score and Amsel's criteria for intermediate Nugent results. The reference methods for Candida infection were isolation of any potential Candida microorganisms from inoculation of two culture media: chromogenic and Sabouraud agar and sequencing. The reference methods for trichomoniasis were wet mount and culture.
RESULTS: For clinician-collected swabs, by reference methods, bacterial vaginosis was diagnosed in 56.5%, vaginal candidiasis in 32.8%, trichomoniasis in 8%, and none of the three infections in 24% with a coinfection rate of 20%. The investigational test sensitivity was 90.5% (95% confidence interval [CI] 88.3-92.2%) and specificity was 85.8% (95% CI 83.0-88.3%) for bacterial vaginosis. The investigational test sensitivity was 90.9% (95% CI 88.1-93.1%) and specificity was 94.1% (95% CI 92.6-95.4%) for the Candida group. Sensitivity for Candida glabrata was 75.9% (95% CI 57.9-87.8%) and specificity was 99.7% (95% CI 99.3-99.9%). Investigational test sensitivity was 93.1% (95% CI 87.4-96.3%) and specificity was 99.3% (95% CI 98.7-99.6%) for trichomoniasis.
Results from self-collected swabs were similar to clinician-collected swabs.
CONCLUSION: A molecular-based test using vaginal swabs collected by clinicians or patients can accurately diagnose most common bacterial, fungal, and protozoan causes of vaginitis. Women and their clinicians seeking accurate diagnosis and appropriate selection of efficacious treatment for symptoms of vaginitis might benefit from this molecular test.
(Obstet Gynecol 2017;0:1-9) DOI: 10.1097/AOG.0000000000002090 V aginitis is a common problem for women associated with discomfort. Symptomatic vaginitis accounts for millions of clinical visits annually. 1 The main diagnoses are bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. 2 In a review of symptomatic women, bacterial vaginosis was diagnosed in 22-50%, vulvovaginal candidiasis in 17-39%, and trichomoniasis in 4-35%. 3 Lactobacilli have predominant roles in the commensal vaginal flora by producing lactic acid. 4, 5 Lactobacillus crispatus and Lactobacillus jensenii are common lactobacilli in the vaginas of healthy women. 6 In bacterial vaginosis, lactobacilli are decreased, with increases in microorganisms such as Atopobium vaginae, Gardnerella vaginalis, Mobiluncus mulieris, Prevotella species, BVAB-2, and Megasphaera species. [7] [8] [9] Candida albicans is responsible for 65-90% of vaginal Candida species infections, and non-albicans Candida species are responsible for up to 30%. [10] [11] [12] Trichomoniasis is the most common curable sexually transmitted infection in the world. 1 The Centers for Disease Control and Prevention recommends use of molecular tests for diagnosis. 13 Diagnosis of vaginitis is usually made by clinical findings, wet mount, Amsel criteria, or laboratory tests. 7, 13 Vaginal swab Gram stain with estimates of numbers of microbial flora is an alternative method for the diagnosis of bacterial vaginosis. 14, 15 Inaccurate test results are problematic for treatment efficacy (Carr FL, Thabault P, Levenson S, Friedman RH. Vaginitis in a community based practice [abstract] . Clin Res 1992;40:554A.). 16, 17 A single molecular test with high sensitivity and specificity might provide a clinical benefit. 18 The study objectives were to compare the investigational molecular test with three reference methods for the diagnosis of vaginitis and compare clinician-collected swabs with self-collected swabs. Comparisons for selfcollection were made to demonstrate accuracy could be maintained if self-collection was used for busy clinicians to save time.
MATERIALS AND METHODS
The study design was a diagnostic accuracy crosssectional study (Fig. 1) . At ten clinical centers, all eligible patients were recruited consecutively from clinics identified as sexually transmitted diseases, human immunodeficiency virus, family planning, and gynecology if they reported symptoms of vaginitis (at least one of the following symptoms: abnormal vaginal discharge, painful or frequent urination, vaginal itching or burning or irritation, painful or uncomfortable intercourse, vaginal odor) and enrolled if they provided informed consent and met the minimum age Unauthorized reproduction of this article is prohibited.
required by their institutional review board (18 at nine sites, and 14 at one site). Exclusion criterion was if they were previously enrolled in this study. The clinical centers were either academic medical center clinics or community clinics. Before giving informed consent, each patient reviewed the study procedures, risks, and benefits. After written informed consent to clinical research, vaginal discharge specimens were collected between May and September 2015. Eligible specimens meeting study inclusion criteria were included in the sensitivity, specificity, and prevalence calculations (Appendix 1, available online at http:// links.lww.com/AOG/A954). A single investigational test swab was used by the patient to self-collect a vaginal specimen in the clinic and then placed in a sheath and handed to the clinician (first collected swab at nine clinical sites and last collected swab at one site). Vaginal swabs collected by the clinician were investigational test swab, two cotton swabs, one BD Liquid Amies Elution Swab Collection and Transport System in random order, and lastly one APTIMA swab. The investigational test swab was placed in an investigational test buffer tube to transport the specimen to the laboratory. Three of the ten collection sites were used as laboratory sites for the investigational test and two additional reference laboratories were used for investigational and reference tests.
The investigational tests were performed with the BD MAX System using the investigational test swabs. The investigational test provided positive or negative results for three diagnoses as follows: 1) bacterial vaginosis, by an algorithmic analysis of molecular DNA detection of lactobacilli (Lactobacillus species [L crispatus and L jensenii]) and also with bacteria associated with bacterial vaginosis, G vaginalis, A vaginae, Megasphaera-1, BVAB-2; 2) vaginal candidiasis by molecular DNA detection of a Candida group (C albicans, Candida tropicalis, Candida parapsilosis, and Candida dubliniensis) or Candida glabrata or Candida krusei; and 3) trichomoniasis by molecular DNA detection of trichomonad protozoa. The molecular test was performed on the investigational test device; an automated sample-in and answer-out instrument that combines sample extraction, polymerase chain reaction setup, and real-time polymerase chain reaction on a walkaway platform.
There were three reference methods. Appendix 2, available online at http://links.lww.com/AOG/A954, summarizes the reference methods for each of the three diagnoses. The bacterial vaginosis reference method was comprised of two tests: Amsel's criteria 7 from a wet mount prepared from one cotton swab and Nugent 14 scoring from a split elution swab sample performed at a single reference laboratory. A 50-microliter aliquot from each elution swab sample was placed on a glass microscope slide and air-dried. Each slide was Gram-stained and used for a scored microscopic interpretation. A semiquantitative evaluation of the three bacterial morphotypes (lactobacilli, G vaginalis, and Mobiluncus spp.) and a numeric value were assigned for each type, the sum of which was then totaled: a score of 0-3 interpretation "normal flora," a score of 4-6 interpretation "intermediate flora," and 7-10 interpretation "bacterial vaginosis flora." Each Gram-stained slide was read by two different readers blinded from the result of the other reader. A third reading by an arbiter was required for discordant results, or a score of 4-6 by both readers, or slide "not readable" by both readers. The score was final if the same result was reported by at least two readers. Disagreement across all three readers was resolved by a panel review of the slide for an adjudicated score. If the final Nugent score was 4-6, this indeterminate result was nondiagnostic and therefore Amsel's criteria were used. A modified Amsel-positive result in this study was the presence of at least two of the three following criteria: vaginal pH greater than 4.5, clue cells seen during microscopic examination of the wet mount by expert clinicians, and "whiff test"-positive. The pH was determined from chromatic paper touched to vaginal discharge on the cotton swab that was used for the wet mount or directly. Whiff test was determined after adding potassium hydroxide to the vaginal discharge and detecting a "fishy" amine odor. The discharge criterion of Amsel's was not considered as a result of its poor sensitivity.
The candidiasis reference method was comprised of two tests: a yeast culture from the split elution swab sample performed at a single reference laboratory by inoculating two different culture media: chromogenic medium BD BBL CHROMagar Candida plate that was read after 36-48 hours of incubation at 33-37°C and the BD BBL Sabouraud Dextrose Agar, Emmons plate that was read after 36-48 hours and until 80 hours of incubation at 25-30°C. The growth level was estimated on both media in an increasing manner: 1 colony, 1+, 2+, 3+, 4+ (where n+ represented the number of quadrants showing Candida spp. growth). Identification of the isolated yeast was then performed by bidirectional sequencing of the its2 gene. 19 The trichomoniasis reference method was comprised of two tests: microscopic examination of the wet mount with visualization of motile trichomonads 20 and InPouch TV Culture System inoculated with one cotton swab. Incubation at 35-37°C was Copyright Ó by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc.
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started within 48 hours after inoculation and readings were performed daily over a 5-to 7-day period. If either reference test was positive, the patient's status was established as infected. Both reference tests had to be negative to establish a noninfected patient status. The APTIMA Trichomonas vaginalis Assay performed from the last swab collected was used in case of discordance. A panel of 50 C glabrata and 50 C krusei strains spiked at varying concentrations and 50 negative (defined "contrived") samples was prepared in a unique (not pooled) negative natural vaginal matrix. These were masked, randomly intermixed, and tested at three reference laboratories to supplement the specimens enrolled in the event prevalence of C glabrata and C krusei was low within the enrolled population.
The population demographics were tabulated by geographic area, clinical type, race or ethnicity, age, and education level. Prevalence rate, sensitivity, specificity, positive predictive value, and negative predictive value were calculated according to standard equations. Sensitivity and specificity analyses were stratified by collection method (self-and cliniciancollected) and specimen type (prospective and contrived). The confidence intervals for sensitivity and specificity were calculated using the score method. 21 The confidence intervals for positive predictive value and negative predictive value were calculated using the exact method. Logistic modeling was performed to determine if sensitivity and specificity are statistically different between collection methods or other subgroups. A significant P value, set at #.05, indicates that there is a statistically significant difference.
Institutional review board approvals were obtained locally by all clinical centers. The protocol and ethical consent were reviewed by each center participating in the study. The study was conducted in accordance with the ethical principles derived from the Declaration of Helsinki and Belmont Report and in compliance with U.S. Food and Drug Administration (FDA) and Good Clinical Practice Guidelines set forth by the International Conference on Harmonization (ICH-E6).
RESULTS
A total of 1,763 women were enrolled for investigational test testing, of whom 23 were excluded. Reasons for exclusion of participants were patient withdrawn (13), informed consent process incorrect (7), asymptomatic patient enrolled (2), and more than one specimen obtained for the same patient (1). Of the 1,740 evaluable participants, the sensitivity and specificity Fewer than 25% of participants were treated with either oral or vaginal antibiotics in the 30-day period before the study or with vaginal antifungals in the 14-day period before the study. For bacterial vaginosis, sensitivity for clinician-and self-collected swabs with the use of oral antibiotics was 82.3% and 84.4%, respectively. With the use of antifungals, bacterial vaginosis sensitivity was 80.4% and 80.0%, respectively. The use of antibiotics or antifungals was not shown to have an effect on the sensitivity of the diagnostic test for Candida species (P value range .25-.82). Fewer than 20 women who tested positive for T vaginalis used antibiotics or antifungals. Table 2 illustrates the number of single and multiple infections by bacterial vaginosis organisms, Candida group, C glabrata, C krusei, and T vaginalis. Unauthorized reproduction of this article is prohibited.
prevalence as identified by the reference method and the investigational test was similar ( Table 2 ). For clinician-collected swabs, by reference methods, bacterial vaginosis was diagnosed in 56.5%, Candida group in 31.9%, C glabrata in 1.7%, C krusei in 0%, trichomoniasis in 8%, and none of the three infections in 24% with a coinfection rate of 20%. Total vaginal candidiasis was diagnosed in 32.8%. Self-collected swabs showed very similar prevalence distributions ( Table 2) . The clinical performance of the investigational test for the detection of each organism or group of organisms is shown in Table 3 , which describes the performance of both clinician-and self-collected swabs as well as the contrived specimen results for C glabrata and C krusei. Sensitivity and specificity for bacterial vaginosis, Candida group, C glabrata and T vaginalis against reference method samples was 90.5% and 85.8%, 90.9% and 94.1%, 75.9% and 99.7%, and 93.1% and 99.3%, respectively. For the self-collected swabs, the sensitivity and specificity for bacterial vaginosis, Candida group, C glabrata, and T vaginalis was 90.7% and 84.5%, 92.2% and 91.9%, 86.7% and 99.6%, and 93.2% and 99.3%, respectively.
DISCUSSION
The investigational test is an FDA-approved nucleic acid amplification test for detection of the major causes of vaginitis. The test performed with high sensitivity and specificity in 1,740 evaluable symptomatic patients from which clinician-and selfcollected specimens were obtained and tested. For bacterial vaginosis, the sensitivity of the investigational test compared with the reference methods was 90.5% and the specificity was 85.8%. For vaginal candidiasis, the investigational test sensitivity and specificity were 90.9% and 94.1%, respectively, for STD, sexually transmitted disease; HIV, human immunodeficiency virus; DTA, declined to answer; NA, not available. Data are n (%), median (minimum-maximum), or mean6standard deviation. * Use of antibiotics and antifungals was from medical record abstraction or self-report.
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the Candida group; for C glabrata, sensitivity was 75.9% and the specificity was 99.7%. For the detection of T vaginalis, the investigational test demonstrated a sensitivity and specificity of 93.1% and 99.3%, respectively, indicating performance similar to other FDA nucleic acid amplification test-cleared assays PPV, positive predictive value; NPV, negative predictive value; BV, bacterial vaginosis; NA, not applicable; ND, no data, TV, Trichomonas vaginalis; "Clinician," clinician-collected specimens, "Self," self-collected specimens; "Contrived," samples spiked with isolated strains. Data are % (n/N), % (n/N) (95% confidence interval), or % (95% confidence interval). * Cgroup5Candida albicans, Candida dubliniensis, Candida parapsilosis, and Candida tropicalis. † Candida group sensitivity is 80.0% (140/175) (95% CI 73.5-85.3%) and 96.7% (322/333) (95% CI 94.2-98.2%) when Candida group load was less than 2+ and 2+ or greater after vaginal specimen culture, respectively, for clinician-collected swabs. All Candida group strains isolated from culture and frozen were successfully detected by the investigational test when retesting the isolated strain directly. ‡ Forty-three of 65 false-positive investigational test specimens were confirmed positive for Candida group by a molecular amplification method. § Candida glabrata sensitivity is 40.0% (2/5) (95% CI 11.8-76.9%) and 83.3% (20/24) (95% CI 64.1-93.3%) when C glabrata load was less than 2+ and 2+ or greater after vaginal specimen culture, respectively, for clinician-collected swabs. k All five false-positive investigational test specimens yielded low C glabrata load by a molecular amplification method. ¶ Positive percent agreement. # Negative percent agreement. ** Seven of nine false-negative investigational test specimens were confirmed negative with the TV molecular comparator and two were positive with the TV molecular comparator. The latter two specimens were positive with the TV culture device test after 4 days of incubation. † † Ten of 11 false-positive investigational test specimens were confirmed positive with the TV molecular comparator.
Unauthorized reproduction of this article is prohibited. The investigational test provided a single vaginal swab, single molecular multiplex assay capable of assisting in the diagnosis of the three types of vaginitis. The investigational test performance was comparable with other research molecular assays for these infections. 9, 22, [24] [25] [26] The performance of self-collected swabs could potentially expand available models of care for busy clinicians, saving them time with patients collecting their own specimens and for recurrent cases of vaginitis. Additionally, this assay potentially eliminates time to perform whiff tests and microscopic examinations for clue cells, trichomonas, and yeast.
For T vaginalis analysis, an FDA-cleared amplification assay used for specimens with discordant results between the investigational test and wet preparation revealed that seven of nine investigational test "false-negative" specimens were also negative. This suggested that some samples were perhaps incorrectly read as T vaginalis-positive on wet mount.
Although traditional methods that diagnose bacterial vaginosis have relied on methods such as the microscopic assessment of bacterial morphotypes (Nugent) or some combination of patient examination and vaginal discharge (Amsel) , recent research by Fredricks et al has indicated more complex processes implicating the role of bacterial pathogens in the etiology of bacterial vaginosis. 9, 24, 25 Many of these organisms, such as A vaginae, Prevotella species, and others, can be detected only by amplification tests, because they are not easily grown or are uncultivable. These discoveries have created an opportunity to advance the molecular diagnosis of bacterial vaginosis. Additionally, certain Lactobacillus species (L crispatus and L jensenii but not Lactobacillus iners 9, 25 ) are important contributors to the maintenance of the normal vaginal flora and are decreased or lost in bacterial vaginosis. These dynamic bacterial population changes are complex. 5, 9, 18, 24 A molecular assay based on the presence of lactobacilli and the absence of deleterious organisms represents an opportunity to improve the diagnosis of bacterial vaginosis. 5, 9, 18, 24 Although this new assay performed well, a fuller understanding of its true performance is constrained by the known limitations of the reference methods. 27 Specificity PPV (95% CI) NPV (95% CI) Copyright Ó by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc.
